TY - JOUR T1 - <sup>99m</sup>Tc-HMPAO–Labeled WBC Scan for the Diagnosis of Chronic Recurrent Multifocal Osteomyelitis JF - Journal of Nuclear Medicine Technology JO - J. Nucl. Med. Technol. SP - 299 LP - 301 DO - 10.2967/jnmt.114.138073 VL - 42 IS - 4 AU - Tyler A. Dailey AU - Michael D. Berven AU - Penny J. Vroman Y1 - 2014/12/01 UR - http://tech.snmjournals.org/content/42/4/299.abstract N2 - The goal of this teaching case study is to demonstrate the novel use of 99mTc-HMPAO-labeled white blood cells (WBCs) in diagnosing chronic recurrent multifocal osteomyelitis (CRMO). 99mTc-HMPAO-labeled white blood cells were utilized to diagnose CRMO. Classically, CRMO is evaluated scintigraphically using 99mTc-methylene diphosphonate/hydroxymethylene diphosphonate. 99mTc-HMPAO-labeled WBCs were chosen over 111In-labeled WBCs because of the former's improved imaging characteristics and decreased radiation dose. 99mTc-HMPAO-labeled WBCs were successful in diagnosing CRMO. 99mTc-HMPAO-labeled WBC scanning is specific for the diagnosis of CRMO. ER -